PharmaShots | Incisive News in 3 Shots

Subscribe Now

CORE Study

Ionis Initiates P-III CORE Study of Olezarsen for the Treatment of Severe Hypertriglyceridemia

Ionis Initiates P-III CORE Study of Olezarsen for the Treatment of Severe Hypertriglyceridemia

November 3, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us